Dean Petkanas - Net Worth and Insider Trading
Dean Petkanas Net Worth
The estimated net worth of Dean Petkanas is at least $6,945 dollars as of 2024-10-16. Dean Petkanas is the CEO, 10% Owner of Neuropathix Inc and owns about 23,149,029 shares of Neuropathix Inc (NPTX) stock worth over $6,945. Details can be seen in Dean Petkanas's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dean Petkanas has not made any transactions after 2022-06-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dean Petkanas
Dean Petkanas Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dean Petkanas owns 1 companies in total, including Neuropathix Inc (NPTX) .
Click here to see the complete history of Dean Petkanas’s form 4 insider trades.
Insider Ownership Summary of Dean Petkanas
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NPTX | Neuropathix Inc | 2022-06-09 | director & 10 percent owner & Chief Executive Officer |
Dean Petkanas Latest Holdings Summary
Dean Petkanas currently owns a total of 1 stock. Dean Petkanas owns 23,149,029 shares of Neuropathix Inc (NPTX) as of June 9, 2022, with a value of $6,945.
Latest Holdings of Dean Petkanas
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
NPTX | Neuropathix Inc | 2022-06-09 | 23,149,029 | 0.00 | 6,945 |
Holding Weightings of Dean Petkanas
Dean Petkanas Form 4 Trading Tracker
According to the SEC Form 4 filings, Dean Petkanas has made a total of 4 transactions in Neuropathix Inc (NPTX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Neuropathix Inc is the sale of 320,000 shares on June 9, 2022, which brought Dean Petkanas around $6,400.
Insider Trading History of Dean Petkanas
- 1
Dean Petkanas Trading Performance
Dean Petkanas Ownership Network
Dean Petkanas Owned Company Details
What does Neuropathix Inc do?
Who are the key executives at Neuropathix Inc?
Dean Petkanas is the director & 10 percent owner & Chief Executive Officer of Neuropathix Inc. Other key executives at Neuropathix Inc include 10 percent owner Medical Marijuana, Inc. , Chief Financial Officer Mark Corrao , and Chief Scientific Officer William Kinney .
Neuropathix Inc (NPTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Neuropathix Inc (NPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neuropathix Inc (NPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Neuropathix Inc (NPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neuropathix Inc Insider Transactions
Dean Petkanas Mailing Address
Above is the net worth, insider trading, and ownership report for Dean Petkanas. You might contact Dean Petkanas via mailing address: 3805 Old Easton Road, Doylestown Pa 18902.